Delivery Order SPE2DR25D3012-SPE2DR26F4F9W
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,954.98 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by January 22, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,832.40 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on January 20, 2026, with completion expected by January 21, 2026. This award is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through an open solicitation process. The pharmaceutical will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,416.20 to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 ml vials on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $28,150.37 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This competitively awarded, firm fixed-price contract was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. No set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a $4,614.37 delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials on January 28, 2026, with completion scheduled for January 29, 2026. This non-set-aside contract utilizes firm fixed-price pricing and represents a single pharmaceutical delivery to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on January 5, 2026, with a ceiling value of $6,832.40 and ultimate completion date of January 6, 2026. This non-set-aside contract employs firm fixed pricing and represents a competitive award under AmerisourceBergen's broader relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location, where...
- The Defense Logistics Agency awarded a $39,176.41 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Actemra 400 mg/20 ml vials, with a contract ceiling value of $3,788.05 and an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order valued at $39,386.96 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on November 28, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a $17,966.19 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in...